Why is my non-HDL cholesterol high?

Non-HDL cholesterol includes all cholesterol types except HDL and is a strong predictor of heart disease risk. High levels can result from diet, genetics, lifestyle factors, or underlying conditions, but can be effectively managed through dietary changes, exercise, and sometimes medication.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding Non-HDL Cholesterol

Non-HDL cholesterol represents all the cholesterol in your blood except for the 'good' HDL cholesterol. This measurement includes LDL cholesterol, VLDL cholesterol, intermediate-density lipoprotein (IDL), and other cholesterol-carrying particles that contribute to plaque buildup in your arteries. Many cardiologists now consider non-HDL cholesterol a better predictor of cardiovascular disease risk than LDL cholesterol alone, as it captures all potentially harmful cholesterol particles in one number.

Your non-HDL cholesterol is calculated by subtracting your HDL cholesterol from your total cholesterol. For example, if your total cholesterol is 220 mg/dL and your HDL is 50 mg/dL, your non-HDL cholesterol would be 170 mg/dL. The optimal level for non-HDL cholesterol is less than 130 mg/dL for most adults, though individuals with diabetes or existing heart disease should aim for levels below 100 mg/dL.

Understanding your complete cholesterol profile, including non-HDL cholesterol, provides crucial insights into your cardiovascular health. Regular monitoring through comprehensive testing can help you track your progress and make informed decisions about your health.

Non-HDL Cholesterol Level Categories

Target levels may be lower for individuals with diabetes or existing cardiovascular disease.
Non-HDL Level (mg/dL)CategoryRisk LevelRecommended Action
Less than 130<130 mg/dLOptimalLow riskMaintain healthy lifestyle
130-159130-159 mg/dLAbove optimalModerate riskLifestyle modifications recommended
160-189160-189 mg/dLBorderline highIncreased riskIntensive lifestyle changes, consider medication
190-219190-219 mg/dLHighHigh riskMedication likely needed with lifestyle changes
220 or higher≥220 mg/dLVery highVery high riskImmediate medical intervention required

Target levels may be lower for individuals with diabetes or existing cardiovascular disease.

Normal vs. High Non-HDL Cholesterol Levels

Non-HDL cholesterol levels are categorized based on cardiovascular risk. Understanding where your levels fall can help you and your healthcare provider determine the best course of action for your heart health.

These target levels may be adjusted based on your individual risk factors. People with diabetes, a history of heart disease, or multiple cardiovascular risk factors typically need to maintain lower non-HDL cholesterol levels. Your healthcare provider can help determine your specific target based on your overall health profile and risk assessment.

Common Causes of High Non-HDL Cholesterol

Dietary Factors

Your diet plays a significant role in determining your non-HDL cholesterol levels. Consuming high amounts of saturated fats found in red meat, full-fat dairy products, and tropical oils like coconut and palm oil can raise your cholesterol levels. Trans fats, although largely eliminated from the food supply, can still be found in some processed foods and significantly increase non-HDL cholesterol while lowering beneficial HDL cholesterol.

Additionally, excessive intake of refined carbohydrates and added sugars can increase triglyceride production in the liver, contributing to higher VLDL cholesterol and overall non-HDL cholesterol levels. Foods high in dietary cholesterol, such as egg yolks and organ meats, may also contribute to elevated levels in some individuals, though the impact varies based on genetic factors.

Genetic and Family History

Genetics play a crucial role in cholesterol metabolism. Familial hypercholesterolemia (FH) is an inherited condition affecting about 1 in 250 people, causing very high LDL and non-HDL cholesterol levels from birth. Even without FH, genetic variations can affect how your body produces, processes, and removes cholesterol from the bloodstream.

If you have family members with high cholesterol or early heart disease (before age 55 in men or 65 in women), you may have inherited genes that predispose you to elevated non-HDL cholesterol. These genetic factors can make dietary and lifestyle modifications less effective, often requiring medication to achieve healthy cholesterol levels.

Lifestyle and Environmental Factors

Several lifestyle factors contribute to elevated non-HDL cholesterol. Physical inactivity reduces your body's ability to clear triglycerides and VLDL particles from the bloodstream while also lowering beneficial HDL cholesterol. Smoking damages blood vessel walls and accelerates plaque formation while reducing HDL cholesterol levels. Excessive alcohol consumption can increase triglyceride production in the liver, raising VLDL and non-HDL cholesterol.

Being overweight or obese, particularly carrying excess weight around the midsection, is associated with higher triglycerides, lower HDL cholesterol, and increased non-HDL cholesterol. Even modest weight loss of 5-10% of body weight can significantly improve cholesterol levels.

Medical Conditions That Raise Non-HDL Cholesterol

Several medical conditions can contribute to elevated non-HDL cholesterol levels. Understanding these connections is important for comprehensive management of your cholesterol and overall health.

  • Diabetes and insulin resistance: Poor blood sugar control increases triglyceride production and VLDL cholesterol while often lowering HDL cholesterol
  • Hypothyroidism: An underactive thyroid slows metabolism and reduces the liver's ability to clear cholesterol from the blood
  • Chronic kidney disease: Impaired kidney function affects lipid metabolism and can lead to elevated triglycerides and non-HDL cholesterol
  • Liver disease: The liver produces and clears cholesterol, so liver dysfunction can disrupt normal cholesterol balance
  • Polycystic ovary syndrome (PCOS): This hormonal disorder often causes insulin resistance and abnormal lipid profiles
  • Cushing's syndrome: Excess cortisol production affects fat distribution and cholesterol metabolism

Certain medications can also raise non-HDL cholesterol as a side effect. These include some diuretics, beta-blockers, corticosteroids, immunosuppressants, and certain HIV medications. If you're taking any of these medications and have high non-HDL cholesterol, discuss alternatives with your healthcare provider rather than stopping medication on your own.

Upload your blood test results to track your progress

Seamlessly upload 3rd party biomarker & blood tests to track your whole health in 1 dashboard. Understand what each blood test means and how it fits into the bigger picture of your body and health.

Get diet and lifestyle recommendations based on your blood results, health profile and health goals. You'll also receive a custom supplement recommendation for the precise nutrients your body craves.

Upload Past Blood Test Results

Click or drag file to upload

Once you upload your report, we'll extract the results for your review. Works with top labs including Quest Diagnostics, LabCorp, BioReference, EverlyWell, LetsGetChecked and hundreds of other labs.

Health Risks of Elevated Non-HDL Cholesterol

High non-HDL cholesterol significantly increases your risk of atherosclerosis, the buildup of plaque in your arteries. This process narrows and hardens arteries throughout your body, reducing blood flow and oxygen delivery to vital organs. Over time, this can lead to serious cardiovascular events including heart attacks, strokes, and peripheral artery disease.

Research shows that for every 1% reduction in non-HDL cholesterol, there's approximately a 1% reduction in cardiovascular event risk. The relationship between non-HDL cholesterol and heart disease risk is linear and continuous, meaning even small reductions can provide meaningful benefits. Studies have also found that non-HDL cholesterol is a better predictor of cardiovascular risk than LDL cholesterol alone, particularly in people with diabetes, metabolic syndrome, or high triglycerides.

Beyond cardiovascular disease, elevated non-HDL cholesterol has been associated with increased risk of fatty liver disease, gallstones, and certain types of dementia. The systemic inflammation and oxidative stress associated with high cholesterol levels can affect multiple organ systems throughout the body.

Testing and Monitoring Your Cholesterol

Regular cholesterol testing is essential for understanding your cardiovascular risk and tracking the effectiveness of any interventions. A standard lipid panel measures total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides, from which non-HDL cholesterol can be calculated. For the most accurate results, you typically need to fast for 9-12 hours before testing, though non-fasting tests are becoming more common.

Adults should have their cholesterol checked at least every 4-6 years, starting at age 20. However, more frequent testing is recommended if you have risk factors for heart disease, a family history of high cholesterol, or are making lifestyle changes or taking medications to manage your levels. Advanced testing that includes apolipoprotein B (ApoB) and lipoprotein(a) can provide additional insights into your cardiovascular risk profile.

If you already have recent blood test results, you can get a comprehensive analysis of your cholesterol levels and personalized recommendations through SiPhox Health's free upload service. This service provides clear explanations of your results and actionable steps to improve your cardiovascular health.

Dietary Strategies to Lower Non-HDL Cholesterol

Making strategic dietary changes can significantly reduce your non-HDL cholesterol levels. The most effective approach combines reducing harmful fats while increasing foods that actively help lower cholesterol.

Focus on incorporating more soluble fiber from sources like oats, barley, beans, lentils, apples, and psyllium. Soluble fiber binds to cholesterol in your digestive system and helps remove it from your body. Aim for at least 5-10 grams of soluble fiber daily. Plant sterols and stanols, found in fortified foods or supplements, can also block cholesterol absorption and lower non-HDL cholesterol by up to 10%.

Replace saturated fats with unsaturated fats from sources like olive oil, avocados, nuts, and fatty fish. Omega-3 fatty acids from fish like salmon, mackerel, and sardines can lower triglycerides and VLDL cholesterol. Consider following a Mediterranean-style diet, which emphasizes whole grains, fruits, vegetables, legumes, nuts, and olive oil while limiting red meat and processed foods.

Exercise and Lifestyle Modifications

Regular physical activity is one of the most effective ways to improve your cholesterol profile. Aerobic exercise helps lower triglycerides and VLDL cholesterol while raising beneficial HDL cholesterol. Aim for at least 150 minutes of moderate-intensity exercise or 75 minutes of vigorous exercise weekly. Activities like brisk walking, jogging, cycling, swimming, or dancing can all be effective.

Resistance training also plays a role in cholesterol management by improving insulin sensitivity and body composition. Include strength training exercises at least twice weekly, targeting all major muscle groups. Even modest increases in physical activity can lead to improvements in non-HDL cholesterol levels.

  • Quit smoking: Smoking cessation can improve HDL cholesterol levels within weeks and reduce overall cardiovascular risk
  • Limit alcohol: If you drink, do so in moderation (up to one drink daily for women, two for men)
  • Manage stress: Chronic stress can negatively impact cholesterol levels through both physiological and behavioral pathways
  • Prioritize sleep: Aim for 7-9 hours of quality sleep nightly to support healthy metabolism
  • Maintain a healthy weight: Even modest weight loss can improve cholesterol levels significantly

When to Consider Medication

While lifestyle modifications are the foundation of cholesterol management, medication may be necessary when non-HDL cholesterol remains elevated despite your best efforts. Your healthcare provider will consider your overall cardiovascular risk, including factors like age, blood pressure, smoking status, and family history, when determining if medication is appropriate.

Statins are typically the first-line medication for lowering non-HDL cholesterol, reducing levels by 30-50% on average. Other options include ezetimibe (which blocks cholesterol absorption), PCSK9 inhibitors (powerful injectable medications for severe cases), bile acid sequestrants, and fibrates (particularly effective for high triglycerides). Some people benefit from combination therapy using multiple medications to achieve target levels.

The decision to start medication should be made in consultation with your healthcare provider, considering both the benefits and potential side effects. Regular monitoring is important to ensure the medication is working effectively and to watch for any adverse effects. Many people can eventually reduce or eliminate cholesterol medications through sustained lifestyle changes, though those with genetic conditions may need long-term treatment.

Taking Control of Your Cholesterol Health

Managing high non-HDL cholesterol requires a comprehensive approach that addresses diet, exercise, and lifestyle factors while monitoring your progress through regular testing. Start by understanding your current levels and risk factors, then work with your healthcare team to develop a personalized plan that fits your lifestyle and health goals.

Remember that lowering non-HDL cholesterol is a gradual process. Most dietary and lifestyle interventions take 6-12 weeks to show their full effect on cholesterol levels. Be patient and consistent with your efforts, celebrating small improvements along the way. Even modest reductions in non-HDL cholesterol can significantly reduce your cardiovascular risk over time.

Stay informed about your cholesterol levels through regular testing and track your progress over time. Consider using tools and services that help you understand your results and provide personalized recommendations. With the right knowledge, support, and commitment, you can successfully manage your non-HDL cholesterol and protect your long-term cardiovascular health.

References

  1. Brunner FJ, Waldeyer C, Ojeda F, et al. Application of non-HDL cholesterol for population-based cardiovascular risk stratification: results from the Multinational Cardiovascular Risk Consortium. Lancet. 2019;394(10215):2173-2183.[PubMed][DOI]
  2. Carr SS, Hooper AJ, Sullivan DR, Burnett JR. Non-HDL-cholesterol and apolipoprotein B compared with LDL-cholesterol in atherosclerotic cardiovascular disease risk assessment. Pathology. 2019;51(2):148-154.[PubMed][DOI]
  3. Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol. Circulation. 2019;139(25):e1082-e1143.[PubMed][DOI]
  4. Langlois MR, Nordestgaard BG, Langsted A, et al. Quantifying atherogenic lipoproteins for lipid-lowering strategies: consensus-based recommendations from EAS and EFLM. Clin Chem Lab Med. 2020;58(4):496-517.[PubMed][DOI]
  5. Ference BA, Ginsberg HN, Graham I, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. Eur Heart J. 2017;38(32):2459-2472.[PubMed][DOI]
  6. Sniderman AD, Thanassoulis G, Glavinovic T, et al. Apolipoprotein B Particles and Cardiovascular Disease: A Narrative Review. JAMA Cardiol. 2019;4(12):1287-1295.[PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my non-HDL cholesterol at home?

You can test your non-HDL cholesterol at home with SiPhox Health's Heart & Metabolic Program, which includes comprehensive cholesterol testing including total cholesterol, HDL, LDL, triglycerides, and advanced markers like ApoB. The program provides lab-quality results and personalized insights to help you manage your cardiovascular health.

What's the difference between non-HDL cholesterol and LDL cholesterol?

LDL cholesterol only measures low-density lipoprotein particles, while non-HDL cholesterol includes all potentially harmful cholesterol types: LDL, VLDL, IDL, and remnant particles. Non-HDL cholesterol provides a more complete picture of cardiovascular risk, especially for people with high triglycerides or diabetes.

How quickly can I lower my non-HDL cholesterol?

With dietary changes and increased exercise, you may see improvements in 6-12 weeks. Medications like statins can show effects within 4-6 weeks. The rate of change depends on your starting levels, the interventions used, and individual factors like genetics and overall health.

Can I have high non-HDL cholesterol even if my LDL is normal?

Yes, this is possible if you have elevated triglycerides or VLDL cholesterol. This pattern is common in people with metabolic syndrome, diabetes, or insulin resistance. That's why measuring non-HDL cholesterol provides valuable information beyond LDL alone.

What foods should I avoid if my non-HDL cholesterol is high?

Limit saturated fats from red meat and full-fat dairy, avoid trans fats in processed foods, reduce refined carbohydrates and added sugars, and minimize fried foods. Focus instead on whole grains, lean proteins, fruits, vegetables, and healthy fats from nuts, seeds, and fish.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details